Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.23 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.33.
Market Cap
9.23T
Revenue
4.66T
Profits
187.12B
PE Ratio
49.33
Profit Margin
4.01%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -1.98% | 1,176,567 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 629.49B | -0.33% | 1,689,114 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 440.81B | -0.55% | 1,523,940 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 359.76B | 0.44% | 1,978,069 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 333.76B | -0.20% | 2,626,036 | 66.57B |
| 6 | NVS | Novartis AG | 289.45B | -0.30% | 1,177,061 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.10B | -0.71% | 2,422,645 | 61.37B |
| 8 | AMGN | Amgen Inc. | 223.82B | -0.92% | 510,000 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 219.07B | -0.57% | 381,065 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 203.52B | -1.46% | 6,074,669 | 50.34B |
| 11 | ABT | Abbott Laboratories | 192.75B | 0.11% | 2,447,447 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 171.19B | -0.06% | 1,484,450 | 30.46B |
| 13 | PFE | Pfizer Inc. | 153.06B | 0.21% | 12,692,327 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.91B | -0.29% | 944,005 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 140.71B | -0.74% | 918,489 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 131.08B | -0.74% | 3,257,597 | 49.19B |
| 17 | SYK | Stryker Corporation | 130.30B | -0.41% | 1,635,659 | 25.84B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 128.68B | -1.69% | 292,906 | 12.59B |
| 19 | CVS | CVS Health Corporation | 123.84B | 1.94% | 5,568,826 | 412.65B |
| 20 | MDT | Medtronic plc | 117.31B | 1.18% | 4,554,377 | 36.36B |
| 21 | SNY | Sanofi | 105.64B | -0.34% | 1,849,979 | 55.89B |
| 22 | MCK | McKesson Corporation | 100.66B | 0.78% | 360,051 | 410.98B |
| 23 | GSK | GSK plc | 98.67B | -2.16% | 2,062,708 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 87.94B | -1.35% | 432,263 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.93B | 0.66% | 216,443 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.42B | -0.07% | 142,649 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 75.47B | 0.74% | 10,015,176 | 21.00B |
| 28 | CI | The Cigna Group | 74.27B | 1.10% | 324,943 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.34B | 0.31% | 691,638 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.30B | 1.35% | 1,809,182 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 54.04B | 0.49% | 538,351 | 254.25B |
| 32 | EW | Edwards Lifesciences Corporation | 53.01B | -0.65% | 1,120,867 | 6.51B |
| 33 | ARGX | argenx SE | 52.87B | -1.40% | 162,947 | 5.32B |
| 34 | BDX | Becton, Dickinson and Company | 49.86B | 0.60% | 364,691 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.82B | 0.08% | 1,450,770 | 29.94B |
| 36 | HUM | Humana Inc. | 46.34B | 0.24% | 309,568 | 145.68B |
| 37 | NTRA | Natera, Inc. | 44.71B | -0.18% | 803,783 | 2.71B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 43.49B | -2.63% | 184,063 | 4.55B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.46B | 0.39% | 382,815 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.64B | 0.19% | 1,070,701 | 17.32B |
| 41 | HLN | Haleon plc | 42.55B | -1.02% | 2,115,418 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 41.94B | -0.54% | 263,502 | 7.23B |
| 43 | WAT | Waters Corporation | 40.47B | -0.37% | 171,154 | 4.64B |
| 44 | VEEV | Veeva Systems Inc. | 40.05B | -2.42% | 645,332 | 3.32B |
| 45 | ONC | BeOne Medicines AG | 39.47B | -2.49% | 184,135 | 6.13B |
| 46 | IQV | IQVIA Holdings Inc. | 39.09B | -1.67% | 328,879 | 16.98B |
| 47 | ALC | Alcon Inc. | 35.39B | 1.03% | 619,433 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 33.88B | -1.86% | 1,636,619 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.75B | 0.22% | 633,802 | 2.54B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 33.29B | -0.11% | 633,226 | 21.27B |
| 51 | CNC | Centene Corporation | 33.17B | 1.67% | 833,520 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.43B | -0.84% | 497,800 | 5.65B |
| 53 | BIIB | Biogen Inc. | 31.03B | -0.31% | 205,190 | 10.03B |
| 54 | ZTS | Zoetis Inc. | 30.67B | -2.14% | 1,943,170 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.46B | 0.24% | 707,186 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.04B | -0.15% | 429,667 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.30B | -1.30% | 55,359 | 4.13B |
| 58 | INSM | Insmed Incorporated | 26.96B | -2.27% | 1,031,119 | 1.14B |
| 59 | PHG | Koninklijke Philips N.V. | 26.78B | -0.31% | 263,119 | 20.18B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.21B | 0.03% | 2,271,257 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 26.04B | -0.03% | 173,477 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 26.00B | -0.62% | 123,143 | 14.35B |
| 63 | MRNA | Moderna, Inc. | 25.34B | -0.28% | 2,611,988 | 2.23B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.51B | 0.61% | 124,011 | 3.33B |
| 65 | INCY | Incyte Corporation | 24.32B | -0.46% | 300,896 | 5.82B |
| 66 | BNTX | BioNTech SE | 23.22B | 0.34% | 329,030 | 3.03B |
| 67 | STE | STERIS plc | 22.77B | -1.07% | 195,038 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 21.50B | -0.02% | 147,977 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.39B | -0.50% | 194,691 | 3.15B |
| 70 | GH | Guardant Health, Inc. | 21.28B | -0.58% | 314,124 | 1.18B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 19.08B | 0.49% | 889,780 | 8.51B |
| 72 | GMAB | Genmab A/S | 18.65B | 1.88% | 2,647,043 | 4.13B |
| 73 | VTRS | Viatris Inc. | 18.56B | 0.75% | 3,086,780 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 16.32B | 0.51% | 353,798 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.16B | -0.51% | 107,745 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.87B | -0.54% | 220,601 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.68B | -1.22% | 1,890,621 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.57B | 1.56% | 803,947 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.22B | 3.39% | 636,539 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.89B | -0.35% | 322,572 | 4.23B |
| 81 | BAX | Baxter International Inc. | 13.80B | -1.29% | 2,145,313 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.28B | -1.12% | 326,076 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.09B | -1.34% | 551,486 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 13.05B | -0.47% | 287,400 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.90B | 0.22% | 65,367 | 1.50B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.85B | 2.41% | 541,469 | 14.37B |
| 87 | ALGN | Align Technology, Inc. | 12.84B | 2.58% | 532,187 | 4.14B |
| 88 | ICLR | ICON Public Limited Company | 12.62B | -2.37% | 113,188 | 8.29B |
| 89 | EXEL | Exelixis, Inc. | 12.61B | 0.59% | 656,827 | 2.44B |
| 90 | SNN | Smith & Nephew plc | 12.55B | -1.08% | 663,867 | 6.30B |
| 91 | FMS | Fresenius Medical Care AG | 12.53B | 0.34% | 358,021 | 22.19B |
| 92 | CORT | Corcept Therapeutics Incorporated | 12.41B | 3.85% | 395,270 | 830.81M |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.29B | 1.67% | 366,425 | 669.50M |
| 94 | EHC | Encompass Health Corporation | 12.22B | 0.22% | 220,899 | 6.21B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.74B | 4.40% | 2,489,420 | 5.02B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | 0.08% | 111,858 | 1.28B |
| 97 | DVA | DaVita Inc. | 11.55B | 1.08% | 199,462 | 14.01B |
| 98 | GMED | Globus Medical, Inc. | 11.50B | -0.36% | 341,129 | 3.14B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.29B | 0.88% | 202,781 | 776.57M |
| 100 | TECH | Bio-Techne Corporation | 11.25B | 0.04% | 1,040,030 | 1.22B |
| 101 | HALO | Halozyme Therapeutics, Inc. | 11.19B | -2.07% | 904,717 | 1.66B |
| 102 | MOH | Molina Healthcare, Inc. | 11.06B | 3.23% | 190,142 | 42.47B |
| 103 | GKOS | Glaukos Corporation | 10.97B | -1.76% | 312,210 | 612.84M |
| 104 | SMMT | Summit Therapeutics Inc. | 10.68B | -4.36% | 6,303,527 | - |
| 105 | ABVX | ABIVAX Société Anonyme | 10.60B | -2.33% | 574,058 | 5.67M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.49B | -0.93% | 853,098 | 3.50B |
| 107 | ENSG | The Ensign Group, Inc. | 10.48B | -0.30% | 74,218 | 5.49B |
| 108 | CYTK | Cytokinetics, Incorporated | 10.26B | 0.50% | 1,038,565 | 67.67M |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 10.22B | -0.64% | 154,644 | 7.46M |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.15B | 0.07% | 968,365 | - |
| 111 | HSIC | Henry Schein, Inc. | 10.05B | 0.09% | 309,995 | 13.60B |
| 112 | OSCR | Oscar Health, Inc. | 10.05B | 5.91% | 3,946,760 | 15.32B |
| 113 | UHS | Universal Health Services, Inc. | 10.03B | -0.62% | 146,073 | 18.11B |
| 114 | PODD | Insulet Corporation | 10.00B | -1.55% | 335,843 | 3.05B |
| 115 | PTGX | Protagonist Therapeutics, Inc. | 9.97B | 1.74% | 164,240 | 281.99M |
| 116 | KRYS | Krystal Biotech, Inc. | 9.76B | 0.39% | 82,613 | 440.48M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.64B | 1.31% | 165,365 | 105.00M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 9.58B | -0.83% | 53,622 | 2.59B |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.46B | 1.92% | 679,644 | 874.09M |
| 120 | RGEN | Repligen Corporation | 9.46B | 0.09% | 326,999 | 785.10M |
| 121 | TEM | Tempus AI, Inc. | 9.42B | -3.89% | 1,589,842 | 1.43B |
| 122 | AVTR | Avantor, Inc. | 9.27B | -1.08% | 1,426,057 | 6.56B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.04B | 0.66% | 313,493 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.26% | 1,695,467 | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.88B | -0.68% | 1,310,687 | 2.10B |
| 126 | BRKR | Bruker Corporation | 8.81B | -0.18% | 473,600 | 3.50B |
| 127 | HQY | HealthEquity, Inc. | 8.79B | -0.41% | 142,839 | 1.34B |
| 128 | PCVX | Vaxcyte, Inc. | 8.63B | -1.44% | 309,275 | - |
| 129 | IMVT | Immunovant, Inc. | 8.59B | -0.55% | 315,736 | - |
| 130 | ATR | AptarGroup, Inc. | 8.40B | -0.29% | 107,338 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.25B | -0.61% | 393,593 | 1.67B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.05B | 0.80% | 138,675 | 239.92M |
| 133 | IBRX | ImmunityBio, Inc. | 7.96B | -1.83% | 2,945,750 | 165.79M |
| 134 | TWST | Twist Bioscience Corporation | 7.54B | -4.07% | 721,774 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.41B | -2.24% | 1,079,171 | 616.91M |
| 136 | ORKA | Oruka Therapeutics, Inc. | 7.23B | 1.05% | 624,378 | - |
| 137 | HNGE | Hinge Health, Inc. | 7.13B | 1.12% | 529,710 | 720.06M |
| 138 | PACS | PACS Group, Inc. | 7.07B | -0.78% | 272,570 | 5.55B |
| 139 | GRFS | Grifols, S.A. | 7.01B | -0.32% | 114,985 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.95B | -0.65% | 100,329 | 2.60B |
| 141 | TGTX | TG Therapeutics, Inc. | 6.89B | 1.34% | 382,210 | 799.54M |
| 142 | LQDA | Liquidia Corporation | 6.66B | 3.22% | 1,483,263 | 450.91M |
| 143 | CGON | CG Oncology, Inc. | 6.65B | 0.40% | 348,888 | 6.23M |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.61B | -1.46% | 5,284,592 | 2.58B |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.06% | 375,824 | 1.56B |
| 146 | COGT | Cogent Biosciences, Inc. | 6.55B | 1.13% | 616,686 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.51B | 1.47% | 293,215 | 618.07M |
| 148 | DNTH | Dianthus Therapeutics, Inc. | 6.45B | 5.26% | 426,349 | 1.90M |
| 149 | SRRK | Scholar Rock Holding Corporation | 6.40B | -1.00% | 251,259 | - |
| 150 | ERAS | Erasca, Inc. | 6.31B | 1.01% | 1,058,778 | - |
| 151 | BLTE | Belite Bio, Inc | 6.28B | -3.98% | 163,858 | - |
| 152 | CAI | Caris Life Sciences, Inc. | 6.14B | -1.98% | 2,179,756 | 989.61M |
| 153 | BLCO | Bausch + Lomb Corporation | 6.05B | -0.18% | 108,629 | 5.32B |
| 154 | RDNT | RadNet, Inc. | 6.02B | -1.00% | 151,597 | 2.27B |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 6.02B | -3.21% | 513,452 | 7.50M |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.97B | -0.57% | 196,927 | 1.01B |
| 157 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.95B | -1.94% | 240,989 | 840.85M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 1.91% | 86,622 | 290.54M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.85B | 1.04% | 416,309 | 591.33M |
| 160 | TFX | Teleflex Incorporated | 5.77B | -0.85% | 168,115 | 2.25B |
| 161 | STVN | Stevanato Group S.p.A. | 5.75B | -2.09% | 241,603 | 1.40B |
| 162 | DFTX | Definium Therapeutics, Inc. | 5.69B | -3.51% | 912,725 | - |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 5.66B | 2.55% | 621,607 | 3.12B |
| 164 | MMED | MiniMed Group, Inc. | 5.65B | 0.55% | 592,693 | 3.10B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.41B | 0.06% | 363,236 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.39B | -0.63% | 415,615 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.14B | -1.46% | 465,224 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.87B | -0.39% | 494,865 | 1.14B |
| 169 | LFST | LifeStance Health Group, Inc. | 4.83B | 3.48% | 3,009,183 | 1.58B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.79B | -1.27% | 871,396 | - |
| 171 | WAY | Waystar Holding Corp. | 4.76B | -0.96% | 658,925 | 1.21B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.75B | 1.20% | 339,932 | - |
| 173 | MANE | Veradermics, Incorporated | 4.72B | 1.72% | 249,350 | - |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.69B | 3.15% | 197,740 | - |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.58B | 1.48% | 276,159 | 1.33B |
| 176 | ICUI | ICU Medical, Inc. | 4.57B | -0.28% | 65,696 | 2.16B |
| 177 | NVST | Envista Holdings Corporation | 4.54B | 0.57% | 912,604 | 2.86B |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.52B | 0.87% | 251,991 | 2.29B |
| 179 | CELC | Celcuity Inc. | 4.50B | 6.21% | 909,945 | - |
| 180 | LIVN | LivaNova PLC | 4.50B | -0.67% | 229,570 | 1.47B |
| 181 | DOCS | Doximity, Inc. | 4.48B | -5.45% | 2,133,272 | 655.57M |
| 182 | BLLN | BillionToOne, Inc. | 4.39B | -1.11% | 261,029 | 397.41M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.31B | -1.25% | 740,319 | 10.35M |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.30B | 1.03% | 165,116 | - |
| 185 | ITGR | Integer Holdings Corporation | 4.26B | 0.18% | 140,549 | 1.84B |
| 186 | TNGX | Tango Therapeutics, Inc. | 4.25B | -1.72% | 739,162 | 53.81M |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.14B | 1.96% | 257,528 | 825.34M |
| 188 | HAE | Haemonetics Corporation | 4.13B | 0.46% | 177,089 | 1.35B |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.01B | -4.15% | 71,321 | 803.79M |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.97B | 1.59% | 858,311 | 308.08M |
| 191 | DNLI | Denali Therapeutics Inc. | 3.91B | -1.49% | 381,729 | 3.60M |
| 192 | LEGN | Legend Biotech Corporation | 3.90B | -0.49% | 765,999 | 1.27B |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.86B | 0.43% | 626,053 | - |
| 194 | GPCR | Structure Therapeutics Inc. | 3.79B | -2.85% | 276,882 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.71B | 0.94% | 478,837 | 117.00M |
| 196 | ABCL | AbCellera Biologics Inc. | 3.69B | 3.83% | 8,327,213 | 66.17M |
| 197 | HTFL | HeartFlow, Inc. | 3.67B | 36.07% | 7,600,552 | 212.07M |
| 198 | OPCH | Option Care Health, Inc. | 3.61B | - | 381,600 | 5.69B |
| 199 | OGN | Organon & Co. | 3.60B | - | 698,994 | 6.13B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | -1.20% | 208,965 | 234.13M |
| 201 | NHC | National HealthCare Corporation | 3.48B | 1.14% | 89,886 | 1.56B |
| 202 | VCYT | Veracyte, Inc. | 3.37B | -1.71% | 888,000 | 561.90M |
| 203 | QURE | uniQure N.V. | 3.28B | 0.51% | 400,512 | 18.67M |
| 204 | CLDX | Celldex Therapeutics, Inc. | 3.27B | -2.32% | 534,452 | 158.00K |
| 205 | MBX | MBX Biosciences, Inc. | 3.27B | 1.13% | 228,848 | - |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.25B | 0.04% | 532,119 | 463.98M |
| 207 | ALMS | Alumis Inc. | 3.24B | 2.42% | 612,736 | 7.40M |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.18B | -0.15% | 506,817 | 7.12M |
| 209 | WRBY | Warby Parker Inc. | 3.18B | -0.50% | 1,470,936 | 911.61M |
| 210 | PLSE | Pulse Biosciences, Inc. | 3.16B | -1.48% | 200,885 | 1.19M |
| 211 | TMDX | TransMedics Group, Inc. | 3.05B | -1.83% | 224,428 | 668.47M |
| 212 | GRAL | GRAIL, Inc. | 3.05B | 0.06% | 202,145 | 165.26M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 0.67% | 219,712 | 606.33M |
| 214 | BKD | Brookdale Senior Living Inc. | 3.03B | 1.12% | 1,496,212 | 2.93B |
| 215 | IMNM | Immunome, Inc. | 3.01B | 0.30% | 295,087 | 4.02M |
| 216 | IRON | Disc Medicine, Inc. | 3.01B | -2.12% | 133,522 | - |
| 217 | IOVA | Iovance Biotherapeutics, Inc. | 2.99B | 1.23% | 8,434,120 | 324.97M |
| 218 | ZLAB | Zai Lab Limited | 2.92B | -0.21% | 683,162 | 449.61M |
| 219 | ALHC | Alignment Healthcare, Inc. | 2.90B | 4.01% | 2,029,093 | 4.58B |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.84B | 1.03% | 467,740 | 3.37B |
| 221 | PRVA | Privia Health Group, Inc. | 2.82B | 1.42% | 327,510 | 2.36B |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -1.25% | 338,595 | 36.77M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 1.35% | 122,736 | 830.44M |
| 224 | AVAH | Aveanna Healthcare Holdings Inc. | 2.70B | 9.39% | 3,953,024 | 2.60B |
| 225 | ATAI | AtaiBeckley Inc. | 2.69B | 0.07% | 4,547,651 | 4.47M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.65B | 1.88% | 87,416 | - |
| 227 | BEAM | Beam Therapeutics Inc. | 2.63B | -0.68% | 764,406 | 156.04M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 1.60% | 774,921 | - |
| 229 | AXGN | Axogen, Inc. | 2.60B | 0.65% | 323,461 | 251.17M |
| 230 | KOD | Kodiak Sciences Inc. | 2.59B | 3.15% | 366,984 | - |
| 231 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | -0.64% | 505,861 | 717.00M |
| 232 | SLS | SELLAS Life Sciences Group, Inc. | 2.55B | 2.18% | 2,561,013 | - |
| 233 | NEOG | Neogen Corporation | 2.53B | -2.52% | 620,538 | 870.40M |
| 234 | COAG | Hemab Therapeutics Holdings, Inc. | 2.52B | 0.19% | 45,822 | - |
| 235 | NKTR | Nektar Therapeutics | 2.52B | -1.92% | 408,243 | 54.59M |
| 236 | UFPT | UFP Technologies, Inc. | 2.51B | 1.39% | 73,215 | 631.64M |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.49B | - | 489,098 | 71.13M |
| 238 | PHVS | Pharvaris N.V. | 2.46B | 2.94% | 316,568 | - |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.46B | -1.99% | 1,630,735 | 940.61M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.44B | 0.51% | 228,961 | 1.10B |
| 241 | GRDN | Guardian Pharmacy Services, Inc. | 2.43B | -0.12% | 131,413 | 1.46B |
| 242 | CLOV | Clover Health Investments, Corp. | 2.43B | 1.78% | 1,699,529 | 2.48B |
| 243 | BHC | Bausch Health Companies Inc. | 2.42B | 2.05% | 1,621,408 | 10.85B |
| 244 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.42B | -3.49% | 818,220 | -665.00K |
| 245 | ESTA | Establishment Labs Holdings Inc. | 2.39B | 6.20% | 147,411 | 245.82M |
| 246 | CDNA | CareDx, Inc. | 2.36B | -3.63% | 359,105 | 458.09M |
| 247 | BFLY | Butterfly Network, Inc. | 2.36B | -0.11% | 3,270,651 | 112.14M |
| 248 | URGN | UroGen Pharma Ltd. | 2.34B | -0.52% | 162,035 | 188.73M |
| 249 | WGS | GeneDx Holdings Corp. | 2.34B | -0.95% | 182,556 | 454.43M |
| 250 | XRAY | DENTSPLY SIRONA Inc. | 2.33B | 0.82% | 1,107,936 | 3.64B |
| 251 | KLRA | Kailera Therapeutics, Inc. | 2.32B | -0.39% | 152,412 | - |
| 252 | VERA | Vera Therapeutics, Inc. | 2.30B | 10.30% | 4,035,547 | - |
| 253 | ALMR | Alamar Biosciences, Inc. | 2.28B | -0.18% | 67,982 | 100.42M |
| 254 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -1.77% | 287,148 | - |
| 255 | VCEL | Vericel Corporation | 2.26B | -0.77% | 122,792 | 306.30M |
| 256 | RAPP | Rapport Therapeutics, Inc. | 2.25B | -0.78% | 70,731 | 20.00M |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.25B | -0.35% | 68,481 | - |
| 258 | ATRC | AtriCure, Inc. | 2.24B | 1.31% | 109,573 | 569.62M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -0.49% | 181,692 | 959.90M |
| 260 | HCM | HUTCHMED (China) Limited | 2.23B | -0.25% | 2,443 | 549.12M |
| 261 | BHVN | Biohaven Ltd. | 2.23B | -0.74% | 487,487 | - |
| 262 | PGEN | Precigen, Inc. | 2.20B | -5.32% | 4,614,724 | 85.72M |
| 263 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -2.77% | 905,444 | 52.06M |
| 264 | NUVB | Nuvation Bio Inc. | 2.15B | 0.49% | 7,504,480 | 169.90M |
| 265 | ADUS | Addus HomeCare Corporation | 2.12B | -1.37% | 49,080 | 1.48B |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.72% | 220,062 | 1.95B |
| 267 | ADMA | ADMA Biologics, Inc. | 2.10B | -0.21% | 569,501 | 512.28M |
| 268 | SEPN | Septerna, Inc. | 2.09B | -1.00% | 382,635 | 98.88M |
| 269 | ASTH | Astrana Health, Inc. | 2.07B | 6.85% | 264,246 | 3.84B |
| 270 | NEO | NeoGenomics, Inc. | 2.05B | -2.62% | 421,883 | 766.30M |
| 271 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 1.09% | 433,297 | 311.51M |
| 272 | MESO | Mesoblast Limited | 2.04B | -5.91% | 105,205 | 65.38M |
| 273 | GHRS | GH Research PLC | 2.03B | 5.11% | 71,275 | - |
| 274 | PGNY | Progyny, Inc. | 2.02B | 1.51% | 292,735 | 1.31B |
| 275 | STOK | Stoke Therapeutics, Inc. | 1.99B | -1.28% | 291,802 | 27.59M |
| 276 | NVCR | NovoCure Limited | 1.99B | -1.78% | 319,664 | 699.19M |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -1.70% | 537,851 | 98.34M |
| 278 | GENB | Generate Biomedicines, Inc. | 1.96B | 1.80% | 149,634 | 26.48M |
| 279 | SGRY | Surgery Partners, Inc. | 1.96B | -0.39% | 512,751 | 3.37B |
| 280 | NBTX | Nanobiotix S.A. | 1.94B | -1.49% | 182,412 | 38.27M |
| 281 | ZBIO | Zenas BioPharma, Inc. | 1.94B | 1.85% | 344,776 | 1.00M |
| 282 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.02% | 391,838 | - |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.91B | 0.88% | 92,865 | - |
| 284 | KARD | Kardigan, Inc. | 1.91B | -6.46% | 77,888 | - |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.90B | 1.99% | 119,419 | 481.07M |
| 286 | TSHA | Taysha Gene Therapies, Inc. | 1.89B | -3.01% | 1,126,313 | 5.49M |
| 287 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -2.93% | 823,681 | 1.97B |
| 288 | TRLV | Trulieve Cannabis Corp. | 1.86B | 0.73% | 491,510 | 1.14B |
| 289 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -0.82% | 266,862 | 262.43M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.46% | 143,763 | 1.13B |
| 291 | CMPS | COMPASS Pathways plc | 1.82B | -0.90% | 618,421 | - |
| 292 | PRGO | Perrigo Company plc | 1.77B | -0.31% | 688,706 | 4.14B |
| 293 | ZYME | Zymeworks Inc. | 1.77B | -3.22% | 161,011 | 37.13M |
| 294 | IMCR | Immunocore Holdings plc | 1.75B | -0.58% | 77,952 | 430.78M |
| 295 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | 1.15% | 571,592 | 252.25M |
| 296 | BLFS | BioLife Solutions, Inc. | 1.72B | -0.13% | 293,602 | 106.69M |
| 297 | ANAB | AnaptysBio, Inc. | 1.71B | 3.00% | 114,688 | 232.39M |
| 298 | XNCR | Xencor, Inc. | 1.70B | -0.35% | 164,263 | 104.97M |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -4.08% | 6,872,616 | 54.86M |
| 300 | OMCL | Omnicell, Inc. | 1.70B | -1.25% | 160,558 | 1.25B |
| 301 | FTRE | Fortrea Holdings Inc. | 1.69B | -0.11% | 1,046,126 | 2.68B |
| 302 | BRVE | Braveheart Bio, Inc. | 1.69B | 1.39% | 196,541 | - |
| 303 | AAPG | Ascentage Pharma Group International | 1.69B | -1.32% | 136 | 82.08M |
| 304 | AVLN | Avalyn Pharma Inc. | 1.68B | 3.85% | 122,203 | - |
| 305 | INSP | Inspire Medical Systems, Inc. | 1.66B | -1.05% | 155,963 | 898.74M |
| 306 | ETON | Eton Pharmaceuticals, Inc. | 1.65B | 41.67% | 1,472,296 | 105.60M |
| 307 | NTLA | Intellia Therapeutics, Inc. | 1.64B | -0.85% | 1,320,779 | 59.51M |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | 1.83% | 99,202 | 978.38M |
| 309 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | 0.34% | 69,137 | 95.13M |
| 310 | AGL | agilon health, inc. | 1.62B | 8.29% | 116,465 | 5.92B |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.58B | 1.31% | 193,720 | - |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.57B | -2.46% | 850,442 | 1.04B |
| 313 | JBIO | Jade Biosciences, Inc. | 1.57B | 3.59% | 948,194 | - |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.57B | 3.18% | 678,819 | 335.41M |
| 315 | ARDT | Ardent Health, Inc. | 1.56B | 0.36% | 55,648 | 6.41B |
| 316 | TRAX | First Tracks Biotherapeutics, Inc. | 1.56B | -0.95% | 199,798 | - |
| 317 | ABSI | Absci Corporation | 1.56B | -4.12% | 1,402,880 | 1.56M |
| 318 | VIR | Vir Biotechnology, Inc. | 1.55B | 1.61% | 456,975 | 303.23M |
| 319 | INVA | Innoviva, Inc. | 1.53B | 1.93% | 194,960 | 440.00M |
| 320 | PSNL | Personalis, Inc. | 1.52B | -1.25% | 719,052 | 69.67M |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.52B | 0.97% | 680,542 | 815.05M |
| 322 | MAZE | Maze Therapeutics, Inc. | 1.51B | -1.52% | 92,764 | 20.00M |
| 323 | ENOV | Enovis Corporation | 1.51B | 2.22% | 370,237 | 2.30B |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.51B | 1.24% | 214,781 | - |
| 325 | HROW | Harrow, Inc. | 1.51B | 3.63% | 291,616 | 275.59M |
| 326 | CNMD | CONMED Corporation | 1.50B | 0.56% | 68,988 | 1.37B |
| 327 | LBRX | LB Pharmaceuticals Inc | 1.50B | 4.89% | 121,913 | - |
| 328 | HCSG | Healthcare Services Group, Inc. | 1.48B | 2.18% | 379,350 | 1.86B |
| 329 | OMDA | Omada Health, Inc. | 1.48B | -0.90% | 486,523 | 309.76M |
| 330 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.47B | -1.99% | 1,105,447 | 208.78M |
| 331 | AZTA | Azenta, Inc. | 1.46B | -2.03% | 205,400 | 613.81M |
| 332 | ALVO | Alvotech | 1.45B | -0.61% | 333,145 | 562.04M |
| 333 | INNV | InnovAge Holding Corp. | 1.44B | -0.19% | 65,149 | 949.17M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -2.60% | 183,430 | - |
| 335 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 0.22% | 412,860 | - |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.42B | 0.19% | 154,091 | 1.65B |
| 337 | REPL | Replimune Group, Inc. | 1.41B | -0.72% | 1,238,678 | - |
| 338 | AORT | Artivion, Inc. | 1.41B | 1.44% | 280,054 | 471.47M |
| 339 | MLTX | MoonLake Immunotherapeutics | 1.40B | -0.36% | 509,635 | - |
| 340 | PAHC | Phibro Animal Health Corporation | 1.40B | 1.23% | 40,440 | 1.50B |
| 341 | AKTS | Aktis Oncology, Inc. | 1.37B | 3.80% | 116,705 | 10.06M |
| 342 | PNTG | The Pennant Group, Inc. | 1.37B | 1.14% | 85,710 | 1.10B |
| 343 | VOR | Vor Biopharma Inc. | 1.35B | -2.06% | 224,463 | - |
| 344 | SVRA | Savara Inc. | 1.35B | 0.76% | 992,100 | - |
| 345 | SDGR | Schrödinger, Inc. | 1.35B | -2.60% | 464,023 | 259.04M |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.14% | 137,600 | 3.43B |
| 347 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | -1.26% | 158,223 | 28.73M |
| 348 | FRNM | Freenome, Inc. | 1.33B | 1.55% | 358,573 | 34.24M |
| 349 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.52% | 180,655 | - |
| 350 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -8.23% | 195,258 | 1.30M |
| 351 | NUTX | Nutex Health Inc. | 1.31B | 2.38% | 91,691 | 846.72M |
| 352 | NVAX | Novavax, Inc. | 1.31B | -2.46% | 1,052,199 | 413.80M |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.30B | 2.40% | 64,931 | - |
| 354 | IMTX | Immatics N.V. | 1.29B | -1.36% | 140,228 | 43.00M |
| 355 | STAA | STAAR Surgical Company | 1.29B | 1.46% | 483,391 | 339.59M |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.26B | -0.40% | 773,683 | 785.23M |
| 357 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | -0.48% | 201,622 | - |
| 358 | APMD | Apnimed, Inc. | 1.25B | 9.17% | 517,325 | 120.15M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -2.25% | 389,147 | - |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | -1.00% | 341,527 | 337.34M |
| 361 | MGTX | MeiraGTx Holdings plc | 1.24B | 6.04% | 279,039 | 397.50M |
| 362 | OMER | Omeros Corporation | 1.24B | -1.21% | 2,155,381 | 38.42M |
| 363 | TDOC | Teladoc Health, Inc. | 1.24B | -2.08% | 1,231,061 | 2.49B |
| 364 | ANRO | Alto Neuroscience, Inc. | 1.23B | -2.79% | 291,934 | - |
| 365 | MNKD | MannKind Corporation | 1.23B | 2.68% | 1,751,589 | 393.63M |
| 366 | CERT | Certara, Inc. | 1.23B | -1.35% | 656,437 | 421.75M |
| 367 | EYPT | EyePoint, Inc. | 1.22B | 5.19% | 996,219 | 2.79M |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 1.21B | -4.89% | 210,955 | - |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.20B | -2.72% | 269,319 | 804.27M |
| 370 | BVS | Bioventus Inc. | 1.19B | 1.94% | 197,124 | 581.85M |
| 371 | CRON | Cronos Group Inc. | 1.17B | -1.90% | 619,985 | 179.09M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | -1.80% | 402,718 | 1.04B |
| 373 | IRMD | IRADIMED CORPORATION | 1.10B | -1.20% | 66,707 | 86.34M |
| 374 | IVA | Inventiva S.A. | 1.10B | -0.43% | 367,518 | 7.94M |
| 375 | GMRS | GMR Solutions Inc. | 1.08B | -0.21% | 725,857 | 5.88B |
| 376 | AHG | Akso Health Group | 1.06B | -4.62% | 5,992 | 13.83M |
| 377 | WVE | Wave Life Sciences Ltd. | 1.05B | 2.02% | 1,413,013 | 65.37M |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -0.21% | 185,036 | 59.00K |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 1,010,567 | 41.47M |
| 380 | SANA | Sana Biotechnology, Inc. | 1.02B | -7.08% | 2,150,516 | - |
| 381 | OPK | OPKO Health, Inc. | 1.02B | -2.86% | 1,721,740 | 587.90M |
| 382 | ARDX | Ardelyx, Inc. | 1.01B | 3.20% | 2,273,350 | 450.89M |
| 383 | ANNX | Annexon, Inc. | 1.00B | 0.38% | 1,071,522 | - |
| 384 | QDEL | QuidelOrtho Corporation | 996.40M | -3.71% | 354,931 | 2.67B |
| 385 | ODTX | Odyssey Therapeutics, Inc. | 984.25M | -0.87% | 74,112 | 99.00K |
| 386 | JANX | Janux Therapeutics, Inc. | 979.41M | 0.12% | 212,521 | 24.00M |
| 387 | SLDB | Solid Biosciences Inc. | 978.97M | 0.55% | 343,232 | - |
| 388 | CLYM | Climb Bio, Inc. | 952.29M | 12.56% | 1,731,008 | - |
| 389 | KURA | Kura Oncology, Inc. | 951.88M | 6.05% | 811,672 | 77.23M |
| 390 | GERN | Geron Corporation | 934.80M | -5.21% | 5,658,965 | 204.56M |
| 391 | ABUS | Arbutus Biopharma Corporation | 921.97M | 1.75% | 706,990 | 181.72M |
| 392 | DSGN | Design Therapeutics, Inc. | 920.58M | 2.22% | 84,532 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 918.72M | -0.10% | 539,293 | - |
| 394 | COLL | Collegium Pharmaceutical, Inc. | 914.81M | -0.18% | 299,859 | 808.21M |
| 395 | CSTL | Castle Biosciences, Inc. | 914.04M | -2.06% | 114,683 | 357.28M |
| 396 | PCRX | Pacira BioSciences, Inc. | 912.04M | -1.29% | 269,743 | 746.16M |
| 397 | CADL | Candel Therapeutics, Inc. | 898.33M | -0.51% | 1,306,298 | - |
| 398 | CBLL | CeriBell, Inc. | 888.45M | -0.43% | 117,766 | 101.96M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 887.77M | 3.42% | 127,863 | 730.02M |
| 400 | AVR | Anteris Technologies Global Corp. | 882.00M | 1.34% | 364,750 | 2.24M |
| 401 | TBPH | Theravance Biopharma, Inc. | 880.28M | 0.21% | 76,113 | 104.31M |
| 402 | INMD | InMode Ltd. | 873.13M | -0.07% | 140,970 | 374.63M |
| 403 | SGP | SpyGlass Pharma, Inc. | 871.32M | 3.50% | 35,785 | - |
| 404 | TALK | Talkspace, Inc. | 869.75M | -0.10% | 1,234,127 | 245.73M |
| 405 | GLAS | Glass House Brands Inc. | 851.09M | -4.81% | 231,258 | 177.68M |
| 406 | SIBN | SI-BONE, Inc. | 847.97M | -0.16% | 85,855 | 213.60M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 844.92M | -2.05% | 363,228 | 8.22M |
| 408 | HSTM | HealthStream, Inc. | 842.70M | -0.69% | 61,006 | 321.12M |
| 409 | PHAR | Pharming Group N.V. | 839.41M | -2.56% | 13,853 | 366.48M |
| 410 | OBX | Obsidian Therapeutics, Inc. | 836.63M | 2.06% | 19,046 | - |
| 411 | ATTO | Attovia Therapeutics, Inc. | 827.02M | 0.21% | 54,583 | 1.35M |
| 412 | SLN | Silence Therapeutics plc | 825.47M | -1.86% | 485,170 | 615.00K |
| 413 | DBVT | DBV Technologies S.A. | 814.55M | -1.14% | 62,344 | 5.04M |
| 414 | BBNX | Beta Bionics, Inc. | 809.36M | -0.50% | 624,015 | 119.01M |
| 415 | OCS | Oculis Holding AG | 793.87M | 0.31% | 78,115 | 1.45M |
| 416 | AURA | Aura Biosciences, Inc. | 792.30M | -0.13% | 428,979 | - |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 785.68M | 3.11% | 117,847 | 276.79M |
| 418 | FTH | Faeth Therapeutics, Inc. | 783.22M | 6.16% | 264,104 | - |
| 419 | SSII | SS Innovations International, Inc. | 780.51M | 1.83% | 15,197 | 52.40M |
| 420 | VREX | Varex Imaging Corporation | 779.32M | -0.05% | 292,425 | 865.00M |
| 421 | AHCO | AdaptHealth Corp. | 773.77M | 1.75% | 978,178 | 3.36B |
| 422 | DRUG | Bright Minds Biosciences Inc. | 772.26M | -1.71% | 106,046 | - |
| 423 | IMMX | Immix Biopharma, Inc. | 771.19M | -1.28% | 592,073 | - |
| 424 | PHR | Phreesia, Inc. | 762.14M | -2.30% | 163,851 | 495.59M |
| 425 | ACHV | Achieve Life Sciences, Inc. | 753.25M | 0.97% | 1,051,875 | - |
| 426 | PHAT | Phathom Pharmaceuticals, Inc. | 744.26M | 2.07% | 459,977 | 239.66M |
| 427 | STTK | Shattuck Labs, Inc. | 741.18M | 0.89% | 334,175 | 1.00M |
| 428 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 0.30% | 572,376 | 18.30M |
| 429 | CBIO | Crescent Biopharma, Inc. | 731.47M | 2.77% | 135,922 | 11.88M |
| 430 | MNPR | Monopar Therapeutics Inc. | 730.96M | -1.37% | 93,589 | - |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 729.78M | -1.30% | 93,689 | - |
| 432 | EVO | Evotec SE | 727.57M | -2.54% | 24,264 | 819.47M |
| 433 | HELP | Cybin Inc. | 725.21M | 2.18% | 664,427 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.18M | 5.64% | 1,036,050 | 389.32M |
| 435 | NGNE | Neurogene Inc. | 710.40M | -0.36% | 70,110 | 925.00K |
| 436 | GYRE | Gyre Therapeutics, Inc. | 706.72M | 1.91% | 29,366 | 109.82M |
| 437 | RGNX | REGENXBIO Inc. | 700.40M | -0.47% | 411,139 | 174.48M |
| 438 | ALLO | Allogene Therapeutics, Inc. | 696.16M | 1.77% | 2,661,158 | 4.64M |
| 439 | TECX | Tectonic Therapeutic, Inc. | 678.66M | 2.16% | 32,267 | - |
| 440 | BWAY | BrainsWay Ltd. | 676.96M | -0.43% | 86,115 | 56.22M |
| 441 | STLN | Starling Oncology, Inc. | 666.53M | 4.47% | 670,994 | 587.24M |
| 442 | CTEV | Claritev Corporation | 665.02M | -7.06% | 78,040 | 994.67M |
| 443 | ZVRA | Zevra Therapeutics, Inc. | 660.94M | -0.45% | 447,447 | 136.07M |
| 444 | VALN | Valneva SE | 658.72M | 27.43% | 2,722,979 | 163.30M |
| 445 | AGMB | AgomAb Therapeutics NV | 657.95M | -4.20% | 27,749 | - |
| 446 | KIDS | OrthoPediatrics Corp. | 649.61M | -0.52% | 57,417 | 252.72M |
| 447 | ASMB | Assembly Biosciences, Inc. | 646.04M | 5.94% | 207,544 | 74.85M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 645.25M | 0.26% | 337,944 | 92.01M |
| 449 | ANGO | AngioDynamics, Inc. | 644.37M | -0.45% | 107,483 | 320.17M |
| 450 | SOPH | SOPHiA GENETICS SA | 638.66M | -1.54% | 120,180 | 86.17M |
| 451 | SGMT | Sagimet Biosciences Inc. | 633.40M | 9.81% | 1,311,529 | - |
| 452 | TLRY | Tilray Brands, Inc. | 622.47M | -2.34% | 2,438,185 | 915.45M |
| 453 | NVCT | Nuvectis Pharma, Inc. | 619.54M | -1.12% | 59,464 | - |
| 454 | CTKB | Cytek Biosciences, Inc. | 617.42M | -2.86% | 363,713 | 206.71M |
| 455 | MDXG | MiMedx Group, Inc. | 615.11M | 0.48% | 353,126 | 355.17M |
| 456 | CRMD | CorMedix Inc. | 595.49M | -6.14% | 1,624,762 | 462.25M |
| 457 | CERS | Cerus Corporation | 590.47M | 3.17% | 1,070,572 | 221.55M |
| 458 | VSTM | Verastem, Inc. | 590.02M | -2.32% | 550,635 | 87.53M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 582.00M | 4.02% | 281,823 | - |
| 460 | DCTH | Delcath Systems, Inc. | 580.86M | -3.57% | 266,435 | 95.42M |
| 461 | ARVN | Arvinas, Inc. | 579.32M | -1.66% | 242,510 | 316.70M |
| 462 | AUTL | Autolus Therapeutics plc | 564.22M | -4.50% | 1,768,760 | 117.39M |
| 463 | ALT | Altimmune, Inc. | 562.16M | 0.35% | 1,582,826 | 31.00K |
| 464 | SPRY | ARS Pharmaceuticals, Inc. | 559.89M | -7.70% | 3,345,678 | 116.93M |
| 465 | ARTV | Artiva Biotherapeutics, Inc. | 556.86M | 0.80% | 132,377 | 251.00K |
| 466 | PRME | Prime Medicine, Inc. | 547.95M | -2.84% | 853,950 | 4.07M |
| 467 | PRLD | Prelude Therapeutics Incorporated | 547.93M | -0.75% | 276,165 | 22.42M |
| 468 | OVID | Ovid Therapeutics Inc. | 544.88M | -0.36% | 517,259 | 1.58M |
| 469 | TCMD | Tactile Systems Technology, Inc. | 543.65M | 1.22% | 126,456 | 350.31M |
| 470 | ZURA | Zura Bio Limited | 537.60M | -0.36% | 538,277 | - |
| 471 | MPLT | MapLight Therapeutics, Inc. | 535.66M | -0.26% | 247,413 | - |
| 472 | EOLS | Evolus, Inc. | 533.69M | 0.75% | 249,407 | 316.49M |
| 473 | CTNM | Contineum Therapeutics, Inc. | 531.21M | -7.71% | 451,992 | - |
| 474 | EVH | Evolent Health, Inc. | 526.29M | -0.11% | 994,149 | 2.10B |
| 475 | SRTA | Strata Critical Medical, Inc. | 523.72M | -0.84% | 235,822 | 255.98M |
| 476 | AQST | Aquestive Therapeutics, Inc. | 522.76M | -2.00% | 2,838,478 | 54.09M |
| 477 | EVMN | Evommune, Inc. | 519.70M | 1.78% | 167,302 | 10.00M |
| 478 | ANL | Adlai Nortye Ltd. | 519.60M | 1.01% | 18,100 | 5.00M |
| 479 | CCCC | C4 Therapeutics, Inc. | 516.71M | 2.94% | 2,008,945 | 35.04M |
| 480 | FLGT | Fulgent Genetics, Inc. | 510.68M | -0.48% | 55,558 | 323.93M |
| 481 | RLMD | Relmada Therapeutics, Inc. | 508.28M | 0.32% | 393,376 | - |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 502.79M | 0.62% | 332,478 | - |
| 484 | NPCE | NeuroPace, Inc. | 502.16M | 0.83% | 92,820 | 106.99M |
| 485 | OABI | OmniAb, Inc. | 495.05M | -0.73% | 325,231 | 38.46M |
| 486 | BLSM | BlossomHill Therapeutics, Inc. | 493.36M | -1.53% | 188,582 | - |
| 487 | ENTX | Entera Bio Ltd. | 491.72M | -1.05% | 148,183 | 42.00K |
| 488 | RZLT | Rezolute, Inc. | 481.07M | 0.11% | 325,959 | - |
| 489 | BIOA | BioAge Labs, Inc. | 480.54M | 0.38% | 213,688 | 10.36M |
| 490 | CLPT | ClearPoint Neuro, Inc. | 469.77M | -0.13% | 125,158 | 42.28M |
| 491 | NRC | NRC Health | 463.40M | -1.69% | 71,964 | 140.00M |
| 492 | DNA | Ginkgo Bioworks Holdings, Inc. | 463.30M | -4.97% | 780,337 | 132.42M |
| 493 | CABA | Cabaletta Bio, Inc. | 459.47M | - | 1,380,133 | - |
| 494 | PRTA | Prothena Corporation plc | 458.44M | -1.65% | 125,391 | 54.53M |
| 495 | OCGN | Ocugen, Inc. | 456.10M | -0.37% | 1,912,869 | 4.58M |
| 496 | SGHT | Sight Sciences, Inc. | 455.58M | -0.60% | 124,425 | 83.38M |
| 497 | QTTB | Q32 Bio Inc. | 453.39M | -0.91% | 166,121 | 53.74M |
| 498 | NNNN | Anbio Biotechnology | 451.64M | 0.29% | 18,483 | 8.65M |
| 499 | PBYI | Puma Biotechnology, Inc. | 449.09M | -0.11% | 112,349 | 231.24M |
| 500 | LRMR | Larimar Therapeutics, Inc. | 448.32M | 0.59% | 515,943 | - |